跳至主要内容
临床试验/CTRI/2024/01/061941
CTRI/2024/01/061941尚未招募不适用

A comparative study to evaluate the impact of Atorvastatin versus Rosuvastatin on the Lipid profile and Vitamin D concentration in Dyslipidemic patients of eastern Uttar Pradesh population

Dr Ashutosh Roy1 个研究点 分布在 1 个国家目标入组 128 人开始时间: 2024年1月31日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
128
试验地点
1
主要终点
Quality of life

研究概览

简要总结

A prospective randomized parallel group , open label drug trial to evaluate the effect of Atorvastatin versus Rosuvastatin on the Lipid profile and vitamin D concentration along with observing the side effects of both the drugs in patients with Dyslipidemia.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
25.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Patients giving written informed consent for the study.
  • Both genders.
  • All patients 25 years of age with dyslipidaemia not meeting the goal for LDL-C, according to the European Society of Cardiology (ESC) and the European Atherosclerosis Society guidelines for the management of dyslipidaemias.
  • All adult patients age (25-65 years) willing to take medication as directed and ready to come for the follow up.

排除标准

  • 未提供

结局指标

主要结局

Quality of life

时间窗: Base line, 1st month, 2nd month, 3rd month

次要结局

  • Lipid profile, Vitamin D Concentration, Adverse drug reaction.(Every month for 3 month)

研究者

发起方
Dr Ashutosh Roy
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Ashutosh Roy

B R D Medical College

研究点 (1)

Loading locations...

相似试验